Cannabis found in Haribo confectionery not from production process: Manufacturer
In late May, Haribo recalled packets of confectionery in the Netherlands, Belgium and Luxembourg after some were found to contain traces of cannabis.
The food safety body in the Netherlands (NVWA) said three 1-kilogram packs of Haribo Happy Cola F!ZZ were found to be contaminated.
Haribo's investigation, and tests by an independent laboratory, found the cannabis had not entered the product during production, Haribo said.
'We are pleased to confirm that the results of these tests are all negative and there are no signs of contamination,' a Haribo spokesperson said. 'Our internal investigations also show that there were no irregularities in our production processes.'
Haribo was still working closely with authorities to determine how the cannabis could have gotten into the confectionery.
NVWA had also warned that consuming the affected cola bottles could lead to health problems, including dizziness.
Several people, including children, had complained of feeling unwell. Two children were treated in a hospital, and one was temporarily in a coma.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
19 hours ago
- New Straits Times
Pfizer, BioNTech lose UK appeal to Moderna in Covid-19 vaccine patent fight
LONDON: US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals Court in London upheld an earlier UK court decision in the long-running battle between the global pharma firms. It found that one of the European patents held by Moderna was invalid, but that a second one had been broken by Pfizer and its German partner BioNTech. "The judge made no error of law or principle" in the ruling handed down in July 2024, the Appeal Court judges wrote Friday, dismissing the appeal brought by the two companies. Pfizer quickly said it will appeal Friday's ruling to Britain's Supreme Court. "Today's UK Court of Appeal's decision does not change our unwavering stance that this patent is invalid," Pfizer said in a statement. "This decision has no immediate impact on Pfizer and BioNTech." Pfizer and BioNTech had argued that both the patents cited by Moderna were invalid, and neither had been infringed. Friday's decision could have wide implications for other cases involving the huge pharma companies in the United States, Germany, Belgium, the Netherlands and Ireland. Moderna said in a statement it was pleased with Friday's ruling and would "continue to pursue and enforce its patent rights globally to protect its innovative mRNA technology." A UK court was told last year the firms had spent £19 million (US$25 million) fighting their legal battles. In 2020, Pfizer and BioNTech's vaccine became the first ever mRNA vaccine approved for widespread use, and was swiftly deployed to combat the Covid pandemic. Scientists believe mRNA vaccines, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against many diseases. Traditional vaccines contain some form of the dead or inactivated target virus. Since the virus need not be grown in the lab, mRNA vaccines can in theory be developed at scale more quickly than traditional vaccines. In March, a German court in Duesseldorf also found Pfizer and BioNTech had violated a Moderna patent filed between 2010 to 2016 to make their vaccines. It ordered they must provide estimates of how much they had profited from breaking the patent as well as provide "appropriate compensation."--AFP
The Star
4 days ago
- The Star
Study: Covid-19 has affected our brains
The strain on people's lives during the pandemic such as weeks of isolation and uncertainty surrounding the crisis may have aged people's brains, researchers believe. — dpa The Covid-19 pandemic was 'detrimental' to brain health, even among people who never caught the infection, a new study reveals. Academics suggest the strain on people's lives – from isolation for weeks on end to the uncertainty surrounding the crisis – may have aged the brains of society. They found that brain ageing during the pandemic was 'more pronounced' among men, older people and people from deprived backgrounds. Brain ageing models were trained on more than 15,000 healthy people. These were then applied to almost 1,000 people taking part in the UK Biobank study – a long-term study tracking the health of middle and older aged adults. Half of the group had brain scans before the pandemic while the others had brain scans before and after the global crisis. After looking at the scans, academics said that the pandemic 'significantly' accelerated brain ageing. This was assessed by their brain age, as determined by the scans, compared with their actual age. The research team found that, on average, the scans taken after people had lived through the crisis had a '5.5-month higher deviation of brain age gap'. 'We found that the Covid-19 pandemic was detrimental to brain health and induced accelerated brain ageing. regardless of SARS-CoV-2 infection,' the experts from the University of Nottingham wrote in the journal Nature Communications . Dr Ali-Reza Mohammadi-Nejad, who led the study, said: 'What surprised me most was that even people who hadn't had Covid showed significant increases in brain ageing rates. 'It really shows how much the experience of the pandemic itself, everything from isolation to uncertainty, may have affected our brain health.' The research team also examined whether having Covid-19 affected someone's cognitive performance by examining the results of tests taken at the time of the scans. They found that people who were infected with the virus appeared to perform more poorly on cognitive tests when they were assessed again after the pandemic. Dr Dorothee Auer, professor of neuroimaging and senior author on the study, added: 'This study reminds us that brain health is shaped not only by illness, but by our everyday environment. 'The pandemic put a strain on people's lives, especially those already facing disadvantage. 'We can't yet test whether the changes we saw will reverse, but it's certainly possible, and that's an encouraging thought.' – PA Media/dpa
Sinar Daily
20-07-2025
- Sinar Daily
Scientists find oldest trace of plague bacterium from 5,500 years ago
The earliest evidence of zoonotic diseases - illnesses transmitted from animals to humans - dates back to about 6,500 years ago and became more widespread about 1,500 years later. 20 Jul 2025 08:00pm A computer screen shows a human skull in a laboratory. (Photo by Roland DE COURSON / AFP) COPENHAGEN - A large-scale study of human disease dating back 37,000 years of harmful bacteria, viruses, and parasites that have afflicted humans for millennia has revealed that the first evidence of the plague bacterium occurred some 5,500 years ago, reported German Press Agency (dpa). The study mapped an entire catalogue of infectious diseases by analysing DNA of bones and teeth from 1,313 individuals who lived across Europe and Asia (Eurasia) from the Early Stone Age, around 12,500 years ago, to about 200 years ago, with the oldest sample dating as far back as 37,000 years ago. The study detected the world's oldest genetic trace of Yersinia pestis, the plague bacterium, in a sample dating back 5,500 years. The plague is estimated to have killed between one-quarter and one-half of Europe's population during the Middle Ages. - AFP file photo for illustration purpose only The researchers found that the earliest evidence of zoonotic diseases - illnesses transmitted from animals to humans - dates back to about 6,500 years ago and became more widespread about 1,500 years later. "We've long suspected that the transition to farming and animal husbandry opened the door to a new era of disease. Now, DNA shows us that it happened at least 6,500 years ago," said Professor Eske Willerslev, from the universities of Cambridge and Copenhagen. "These infections didn't just cause illness - they may have contributed to population collapse, migration, and genetic adaptation." The study detected the world's oldest genetic trace of Yersinia pestis, the plague bacterium, in a sample dating back 5,500 years. The plague is estimated to have killed between one-quarter and one-half of Europe's population during the Middle Ages. It also found traces of diphtheria going back 11,000 years, hepatitis B going back 9,800 years, and malaria 4,200 years ago. In total, researchers identified 214 known human pathogens in prehistoric humans from Eurasia. The study was published in the journal Nature on Wednesday. - BERNAMA-dpa
